American College of Allergy, Asthma and Immunology Report issue

Foundation Phase 2 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01264601
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

American College of Allergy, Asthma and Immunology

Active Ingredients

Drugs in Phase 4 Trials (1)

amoxicillin (1 trial)

Drugs in Phase 2 Trials (2)

phenol (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (1)

inactivated influenza vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rhinitis (Phase 2)

Rhinitis, Allergic (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4